登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Coagulation factor XI】

Coagulation factor XI信息

英文名称:Coagulation factor XI
中文名称:凝血因子XI
靶点别称:EC 3.4.21,EC:3.4.21.27,FXI,F11,PTA,Coagulation Factor XI,Plasma Thromboplastin Antecedent,EC 3.4.21.27,Factor XI,Coagualtion Factor XI
上市药物数量:2
临床药物数量:26
最高研发阶段:批准上市

Coagulation factor XI产品列表

ACRO质量管理体系
 
评论(0)
 

Coagulation factor XI分子别名

Coagulation factor XI,FXI,PTA,F11

Coagulation factor XI分子背景

Coagulation factor XI is also known as F11, PTA and FXI. Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX. Factor XI is synthesized in the liver and circulates in the plasma as a disulfide bond-linked dimer complexed with high molecular weight kininogen. Selective cleavage of Arg-|-Ala and Arg-|-Val bonds in factor IX to form factor IXa. Factor XI is converted into XIa via either the contact phase of blood coagulation or thrombin-mediated activation on the platelet surface. The resulting XIa converts factor IX into IXa, which subsequently activates factor X into Xa.

Coagulation factor XI上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验

Coagulation factor XI临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定